SCHEMBL20037613

SCHEMBL20037613

Cc1ccc(CN(C)S(C)(=O)=O)cn1

nearest known ligand 0.57

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ TSHR P16473 1/20 0.39
▸ GRIA2 P42262 1/20 0.37
▸ USP2 O75604 1/20 0.37
▸ ATM Q13315 2/20 0.36
▸ ALDH1A1 P00352 3/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ NAMPT P43490 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ PTGS2 P35354 1/20 0.35
▸ HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18291420 0.81 GABRP (0.45) SMN1; SMN2GRIA2USP2ALDH1A1MEN1
SCHEMBL20037822 0.81 GRIA2 (0.36) SMN1; SMN2TSHRGRIA2USP2ATM
SCHEMBL21267701 0.80 KMT2A (0.36) SMN1; SMN2GRIA2USP2ALDH1A1MEN1
SCHEMBL12673011 0.79 TAS2R14 (0.48) NAMPT
SCHEMBL21193218 0.79 SMN1; SMN2 (0.46) SMN1; SMN2TSHRALDH1A1NAMPTGAA
SCHEMBL20249183 0.79 ALDH1A1 (0.40) SMN1; SMN2TSHRGRIA2USP2ALDH1A1
SCHEMBL18291549 0.79 GRIA2 (0.38) SMN1; SMN2GRIA2USP2ALDH1A1MEN1
SCHEMBL12910012 0.77 CHRNB2 (0.53) SMN1; SMN2TSHRALDH1A1MEN1KMT2A
SCHEMBL12880767 0.76 CHRNB2 (0.62) ALDH1A1NAMPT
SCHEMBL10192138 0.76 ALDH1A1 (0.49) TSHRGRIA2ATMALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022236253-A1 HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS NUVATION BIO INC. (US) 2022-11-10 — — WO disclosed
WO-2022236256-A1 HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS NUVATION BIO INC. (US) 2022-11-10 — — WO disclosed
EP-3305785-A1 PYRIDO[3,4-d]PYRIMIDINE DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF Teijin Pharma Limited (JP) 2018-04-11 — — EP disclosed
Send feedback